Search hospitals > Tennessee > Knoxville
Alliance for Multispecialty Research, LLC
Claim this profileKnoxville, Tennessee 37920
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Obesity
Conducts research for Coronavirus
Conducts research for Pneumococcal Infections
71 reported clinical trials
6 medical researchers
Summary
Alliance for Multispecialty Research, LLC is a medical facility located in Knoxville, Tennessee. This center is recognized for care of Diabetes, Type 2 Diabetes, Obesity, Coronavirus, Pneumococcal Infections and other specialties. Alliance for Multispecialty Research, LLC is involved with conducting 71 clinical trials across 60 conditions. There are 6 research doctors associated with this hospital, such as William Smith, Lisa Connery, Michael A Rausch, and Harry E Studdard, MD.Top PIs
William SmithAMR Knoxville1 year of reported clinical research
Studies Tobacco Use
Studies Smoking
28 reported clinical trials
48 drugs studied
Lisa ConneryAlliance for Multispecialty Research, LLC1 year of reported clinical research
Expert in Type 2 Diabetes
Expert in Diabetes
22 reported clinical trials
18 drugs studied
Michael A RauschGSK Investigational Site4 years of reported clinical research
Studies Respiratory Syncytial Virus
Studies Flu
9 reported clinical trials
13 drugs studied
Harry E Studdard, MDAlliance for Multispecialty Research, LLC1 year of reported clinical research
Studies Cardiovascular Disease
Studies Chikungunya Fever
7 reported clinical trials
7 drugs studied
Clinical Trials running at Alliance for Multispecialty Research, LLC
Obesity
Type 2 Diabetes
Diabetes
Cardiovascular Disease
Migraine
High Cholesterol
Pneumococcal Infections
Monkeypox
Chronic Kidney Disease
Smoking Cessation
Orforglipron
for Type 2 Diabetes and Obesity
This trial is testing a new diabetes medication called orforglipron to see if it is safer and more effective than insulin in people with type 2 diabetes who are overweight or obese and at higher risk for heart problems. The study will last several years and involve multiple visits.
Recruiting2 awards Phase 3
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting1 award Phase 32 criteria
Orforglipron
for Obesity
This trial will test the safety and effectiveness of an oral medication called orforglipron in adults who are obese or overweight and have related health problems. The medication aims to help reduce body weight by possibly affecting appetite or metabolism.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Alliance for Multispecialty Research, LLC?
Alliance for Multispecialty Research, LLC is a medical facility located in Knoxville, Tennessee. This center is recognized for care of Diabetes, Type 2 Diabetes, Obesity, Coronavirus, Pneumococcal Infections and other specialties. Alliance for Multispecialty Research, LLC is involved with conducting 71 clinical trials across 60 conditions. There are 6 research doctors associated with this hospital, such as William Smith, Lisa Connery, Michael A Rausch, and Harry E Studdard, MD.